John Docherty
Fortune : 35 790 $ au 31/05/2026
Fortune : 35 790 $ au 31/05/2026
John Martin Docherty is currently President, Chief Scientific Officer & Director at Lexaria Bioscience Corp.
since 2015.
Formerly, Mr. Docherty was President & Director at PharmaDerm Laboratories Ltd. from 2004 to 2008 and President & Chief Operating Officer at Helix BioPharma Corp.
from 2007 to 2013.
Education includes undergraduate and graduate degrees from the University of Toronto, conferred in 1993 and 1995 respectively.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/12/2025 | 59 451 ( 0,24% ) | 35 790 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| LEXARIA BIOSCIENCE CORP. | President | 15/04/2015 |
| Sociétés | Poste | Fin |
|---|---|---|
| HELIX BIOPHARMA CORP. | President | 01/12/2013 |
PharmaDerm Laboratories Ltd.
PharmaDerm Laboratories Ltd. Part of Helix BioPharma Corp., PharmaDerm Laboratories Ltd. is a pharmaceutical company based in Saskatoon, Canada. | President | 01/07/2008 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Helix BioPharma Corp.
Helix BioPharma Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention and treatment of cancer | Health Technology |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp. Pharmaceuticals: MajorHealth Technology Engages in drug delivery technology | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmaDerm Laboratories Ltd.
PharmaDerm Laboratories Ltd. Part of Helix BioPharma Corp., PharmaDerm Laboratories Ltd. is a pharmaceutical company based in Saskatoon, Canada. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national